NVIDIA BioNeMo™ is an AI platform for drug discovery that simplifies and accelerates the building and training of models using your own data and scaling the deployment of models for drug discovery applications.
Customize and deploy AI models for 3D protein structure prediction, de novo protein and small molecule generation, property predictions, and molecular docking.
Access pretrained models through cloud APIs or an easy-to-use web interface for interactive inference, visualization, and experimentation.
Experience the ultimate flexibility for experimenting and building enterprise-grade generative AI workflows with GUI and API endpoints on scalable, managed infrastructure.
NVIDIA BioNeMo is powered by NVIDIA DGX™ Cloud, an end-to-end AI platform for developers, offering scalable capacity built on the latest NVIDIA architecture and co-engineered with the world’s leading cloud service providers.
Access documentation, tutorials, and community support for BioNeMo.
NVIDIA BioNeMo Framework is a collection of programming tools and libraries that streamline the building and adapting of biomolecular AI models, accelerating the most time-consuming and costly stages of computational drug discovery.
NVIDIA BioNeMo NIM is a set of optimized, easy-to-use, portable microservices designed for biomolecular scientists in drug discovery needing secure, reliable AI model inferencing.
BioNeMo Framework: Users can access BioNeMo Framework two ways. NVIDIA’s offering for enterprise-grade use of BioNeMo with an NVIDIA AI Enterprise license. BioNeMo Enterprise offers the BioNeMo container via the NVIDIA GPU Cloud, which provides enterprise developers and researchers with a secure, scalable toolchain to build biomolecular workflows. The open-source version of BioNeMo that researchers and data scientists will soon be able to install from GitHub and use all of its components is now available.
BioNeMo microservices: NVIDIA’s offering for enterprise-grade use of BioNeMo with an NVIDIA AI Enterprise license. BioNeMo offers the BioNeMo NIM via the Nvidia GPU Cloud, which provides enterprise developers and researchers with a secure, scalable tool to build biomolecular workflows. BioNeMo NIMs can also be tested on the NVIDIA API Catalog using standard API calls and a UI interface (for some models).
See the latest list of system requirements for BioNeMo Framework on the NGC Catalog Container page.
See the latest system requirements for BioNeMo NIMs at NVIDIA API Documentation.
BioNeMo Framework: Currently offered under NVIDIA AI Enterprise license and will soon be available on GitHub as an open-source resource.
BioNeMo NIMs: Only available under NVIDIA AI Enterprise license and on the NVIDIA API Catalog.
Please contact us with your question.